Skip to main content
Log in

Adult-manifestierende primäre Immundefizienzen

Adult-onset primary immunodeficiencies

  • Schwerpunkt: Abwehr- und Immunschwäche
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Primäre Defekte des Immunsystems können sich bei verschiedenen Individuen entweder in früher Kindheit, spät im Erwachsenenalter oder auch nie manifestieren. Die verschiedenen Phänotypen können teilweise durch die Genotypanalyse oder—bei weiblichen Patienten und X-chromosomalem Erbgang—durch die altersabhängige Verschiebung der Lyonisation erklärt werden. Eine wichtige Rolle spielen wahrscheinlich auch kompensatorische Immunmechanismen. Das Erregerspektrum eines adulten primären Immundefektsyndroms stimmt im Wesentlichen mit demjenigen der juvenilen Form überein. Nicht selten stehen bei den adulten Formen klinisch nicht die Infektkomplikationen, sondern assoziierte Phänomene wie Granulombildung, Autoimmunität oder Neoplasie im Vordergrund. Neben einer adäquaten, erregerspezifischen Antibiose stehen heute für einige primäre Immundefizienzen spezifische Substitutionstherapien in Form von humanem Immunglobulin G Präparationen, rekombinanten Zytokinen oder Enzymen zur Verfügung. Der Einsatz dieser Therapieformen bedingt allerdings eine genaue diagnostische Klassifikation des immunologischen Defekts. Adulte primäre Immundefektsyndrome stellen daher eine Herausforderung für den Kliniker und für den Molekularbiologen dar.

Abstract

Different individuals with the same kind of primary immunodeficiency may start having symptoms from early childhood on, or alternatively much later in adult life, or never. The differences in phenotype can only partly be deduced from genotype-analysis or—in case of female patients with X-linked diseases—from age-related skewing of lyonisation. The role of compensatory immune mechanisms is less clear. The microbial spectrum of infections is usually the same for both adult and infantile forms of a special primary immunodeficiency syndrome. Yet, many of the adult forms are associated with non-infectious complications, such as granuloma formation, autoimmunity or tumors. Besides standard antibiotic treatment and IgG replacement therapy, there are now different cytokine- or enzyme-replacement regimens available for some of the primary immunodeficiencies. However, exact diagnostic classification of the immunodeficiency should be obtained before such treatment modalities are used. Adult primary immunodeficiency syndromes therefore represent a challenge to both clinicians and molecular biologists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Buckley RH (1975) Clinical and immunologic features of selective IgA deficiency. Birth Defects Orig Artic Ser 11: 134–142

    CAS  PubMed  Google Scholar 

  2. Buckley RH (2002) Immunoglobulin G subclass deficiency: fact or fancy. Curr Allergy Asthma Rep 2: 356–360

    PubMed  Google Scholar 

  3. Burrows PD, Cooper MD (1997) IgA deficiency. Adv Immunol 65: 245–276

    CAS  PubMed  Google Scholar 

  4. Chapel H, Geha R, Rosen FS, for the IUIS PID Classification Committee (2003) Primary imunodeficiency disease: an update. Clin Exp Immunol 132: 9–15

    CAS  PubMed  Google Scholar 

  5. Conley M (1999) Autosomal recessive agammaglobulinemia. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press, New York, pp 285–291

  6. Conley M, Rohrer J, Rapalus L, Boylin E et al. (2000) Defects in early B-cell development: comparing the consequences of abnormalities in pre-BCR signalling in the human and the mouse. Immunol Rev 178: 75–90

    Article  CAS  PubMed  Google Scholar 

  7. Cunningham-Rundles C (2001) Common variable immunodeficiency. Curr Allergy Asthma Rep 1: 421–429

    CAS  PubMed  Google Scholar 

  8. Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92: 34–48

    Article  CAS  PubMed  Google Scholar 

  9. Cunningham-Rundles C, Murray HW, Smith JP (1999) Treatment of idiopathic CD4 T lymphocytopenia with IL-2. Clin Exp Immunol 116: 322–325

    Article  CAS  PubMed  Google Scholar 

  10. Cunningham-Rundles C, Siegal FP, Cunninhgam-Rundles S et al. (1989) Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol 7: 294–299

    Google Scholar 

  11. De La Calle-Martin O, Hernandez M, Ordi J et al. (2001) Familial CD8 deficiency due to a mutation in the CD8alpha gene. J Clin Invest 108: 117–123

    Article  PubMed  Google Scholar 

  12. Dupuis S, Dargemont C, Fieschi C et al. (2001) Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 293: 300–303

    Article  CAS  PubMed  Google Scholar 

  13. Elder ME, Lin D, Clever J et al. (1994) Human severe combined immunodeficiency due to a defect in ZAP-70, a T cell tyrosine kinase. Science 264: 1596–1599

    CAS  PubMed  Google Scholar 

  14. Gadola SD, Moins-Teisserenc HT, Trowsdale J et al. (2000) TAP deficiency syndrome. Clin Exp Immunol 121: 173–178

    Article  CAS  PubMed  Google Scholar 

  15. Grimbacher B, Hutloff A, Schlesier M et al. (2003) Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nature Immunol 4: 261–268

    Article  CAS  Google Scholar 

  16. Hammarström L, Smith CIE (1999) Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs HD, Smith CIE, Puck JM (eds) Primary immunodeficiency diseases: a molecular and genetic approach. Oxford University Press, New York, pp 250–262

  17. Hammarström L, Vořechovský I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immundeficiency (CVID) Clin Exp Immunol 120: 225–231

    Google Scholar 

  18. Hershfield MS, Buckley RH, Greenberg ML et al. (1987) Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase. N Engl J Med 316: 589–596

    CAS  PubMed  Google Scholar 

  19. Jones A, Bradley L, Alterman L et al. (1996) X-linked agammaglobulinaemia with a ‚leaky‘ phenotype. Arch Dis Child 74: 548–549

    CAS  PubMed  Google Scholar 

  20. Jong RD de, Altare F, Haagen I et al. (1998) Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280: 1435–1438

    Article  PubMed  Google Scholar 

  21. Kanathur N, Byrd RP, Fields CL et al. (2000) Noncaseating granulomatous disease in common variable immunodeficiency. South Med J 93: 631–633

    CAS  PubMed  Google Scholar 

  22. Kinlin LJ, Webster ADB, Bird AG et al. (1985) Prospective study of cancer in patients with hypogammaglobulinemia. Lancet 1: 263–266

    Article  PubMed  Google Scholar 

  23. Kralovicova J, Hammarstrom L, Plebani A et al.(2003) Fine-scale mapping at IGAD1 and genome-wide genetic linkage analysis implicate HLA-DQ/DR as a major susceptibility locus in selective IgA deficiency and common variable immunodeficiency. J Immunol 170: 2765–2775

    CAS  PubMed  Google Scholar 

  24. Liese JG, Jendrossek V, Jansson A et al. (1996) Chronic granulomatous disease in adults. Lancet 347: 220–223

    Article  CAS  PubMed  Google Scholar 

  25. Lopez Granados E, Porpiglia AS, Hogan MB et al. (2002) Clinical and molecular analysis of patients with defects in micro heavy chain gene. J Clin Invest 110: 1029–1035

    Article  PubMed  Google Scholar 

  26. Lun A, Roesler J, Renz H (2002) Unusual late onset of X-linked chronic granulomatous disease in an adult woman after unsuspicious childhood. Clin Chem 48: 780–781

    CAS  PubMed  Google Scholar 

  27. Mechanic LJ, Dikman S, Cunningham-Rundles C (1997) Granulomatous disease in common variable immunodeficiency. Ann Inter Med 127: 613–617

    CAS  Google Scholar 

  28. Minegishi Y, Coustan-Smith E, Rapalus L et al. (1999): Mutations in Ig alpha (CD79a) result in a complete block in B-cell development. J Clin Invest 104: 1115–1121

    CAS  PubMed  Google Scholar 

  29. Minegishi Y, Coustan-Smith E, Wang YH et al. (1998) Mutations in the human lambda5/14.1 gene result in B cell deficiency and agammaglobulinemia. J Exp Med 187: 71–77

    Article  CAS  PubMed  Google Scholar 

  30. Minegishi Y, Rohrer J, Coustan-Smith E et al. (1999) An essential role for BLNK in human B cell development. Science 286: 1954–1957

    Article  CAS  PubMed  Google Scholar 

  31. Moins-Teisserenc HT, Gadola SD, Cella M et al. (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA-class I-molecules. Lancet 354: 1598–1603

    Article  CAS  PubMed  Google Scholar 

  32. Ottenhoff TH, Kumararatne D, Casanova JL (1998) Novel immunodeficiencies reveal the essential role of type 1 cytokines in immunità to intracellular bacteria. Immunol Today 19: 491–494

    Article  CAS  PubMed  Google Scholar 

  33. Ozsahin H, Arrdondo-Vega FX, Santisteban I et al. (1997) Adenosine deaminase deficiency in adults. Blood 89: 2849–2855

    CAS  PubMed  Google Scholar 

  34. Pan Q, Hammarström L (2000) Molecular basis of IgG subclass deficiency. Immunol Rev 178: 99–110

    Article  CAS  PubMed  Google Scholar 

  35. Pfluger H, Helbling A, Mordasini C, Pichler WJ (2000) CVID (common variable immunodeficiency): heterogene Krankheitsmanifestation dieses häufigsten symptomatischen primären Immundefekts. Schweiz Med Wochenschr 130: 1590–1599

    CAS  PubMed  Google Scholar 

  36. Schauer U, Stemberg F, Rieger CHL et al. (2003) Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults. Clin Diagn Lab Immunol 10: 202–207

    Article  CAS  PubMed  Google Scholar 

  37. Schauer U, Stemberg F, Rieger CHL et al. (2003) IgG subclass concentrations in certified reference material 470 and reference values for children and adults determined with the binding site reagents. Clin Chem 49: 1925–1029

    Google Scholar 

  38. Schultz H, Schinke S, Weiss J et al. (2003) BPI–ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clin Exp Immunol 133: 252–259

    Article  CAS  PubMed  Google Scholar 

  39. Smith DK, Neal JJ, Homberg SD (1993) Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection: an investigation of cases in the United States. The Center for Disease Control idiopathic CD4+ T-lymphocytopenia Task Force. N Engl J Med 328: 373–379

    Article  CAS  PubMed  Google Scholar 

  40. Sneller MC (2001) Common variable immunodeficiency. Am J Med Sci 321: 42–48

    Article  CAS  PubMed  Google Scholar 

  41. Sneller MC, Strober W, Eisenstein E et al. (1993) NIH conference. New insights into common variable immunodeficiency. Ann Intern Med 118: 720–730

    CAS  PubMed  Google Scholar 

  42. Spickett GP (2001) Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 31: 536–542

    Article  CAS  PubMed  Google Scholar 

  43. Vihinen M, Kwan SP, Lester T et al. (1999) Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia. Hum Mutat 13: 280–285

    Article  CAS  PubMed  Google Scholar 

  44. Washington K, Stenzel TT, Buckley RH et al. (1996) Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia. Am J Surg Pathol 20: 1240–1252

    Article  CAS  PubMed  Google Scholar 

  45. Yabe T, Kawamura S, Sato M et al. (2002) A subject with a novel type I bare lymphocyte syndrome has tapasin deficiency due to deletion of 4 exons by Alu-mediated recombination. Blood 100: 1496–1498

    Article  CAS  PubMed  Google Scholar 

  46. Yel L, Minegishi Y, Coustan-Smith E et al. (1996) Mutations in the mu heavy chain gene in patients with agammaglobulinemia. N Engl J Med 335: 1486–1493

    Article  CAS  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to S. Gadola or B. Grimbacher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gadola, S., Salzer, U., Schultz, H. et al. Adult-manifestierende primäre Immundefizienzen. Internist 45, 912–922 (2004). https://doi.org/10.1007/s00108-004-1230-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-004-1230-7

Schlüsselwörter

Keywords

Navigation